Symptom improvement was not significantly associated with weight loss, dose, or treatment duration in women with lipoedema treated with tirzepatide: a retrospective cohort study of prospectively collected outcomes
Elsevier ·
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Symptom improvement was not significantly associated with weight loss, dose, or treatment duration in women with lipoedema treated with tirzepatide: a retrospective cohort study of prospectively collected outcomes. // Metabolism Open. – URL: https://www.sciencedirect.com/science/article/pii/S2589936826000770?dgcid=rss_sd_all
Symptom improvement was not significantly associated with weight loss, dose, or treatment duration in women with lipoedema treated with tirzepatide: a retrospective cohort study of prospectively collected outcomes. Metabolism Open. https://www.sciencedirect.com/science/article/pii/S2589936826000770?dgcid=rss_sd_all
“Symptom improvement was not significantly associated with weight loss, dose, or treatment duration in women with lipoedema treated with tirzepatide: a retrospective cohort study of prospectively collected outcomes.” Metabolism Open.
@article{article58718,
title = {Symptom improvement was not significantly associated with weight loss, dose, or treatment duration in women with lipoedema treated with tirzepatide: a retrospective cohort study of prospectively collected outcomes},
journal = {Metabolism Open},
url = {https://www.sciencedirect.com/science/article/pii/S2589936826000770?dgcid=rss_sd_all}
}